MD-15 Intraocular Lens Phase 3 study

A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1080224664

Enrollment

110

Registered

2019-05-07

Start date

2016-09-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

investigational material(s) Generic name etc : MD-15 (Intraocular lens) INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who intend to undergo phacoemulsification cataract extraction

Exclusion criteria

Exclusion criteria: - Patients who undergo secondary implantation - Patients with vision loss induced by causes other than cataract - Patients who have been deemed ineligible as participants in the study by investigator/subinvestigator

Design outcomes

Primary

Measure	Time frame
efficacy Visual acuity after surgery	—

Secondary

Measure	Time frame
safety efficacy Visual acuity, adverse events, etc.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026